Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS‐1 phase 3 trial

Documents similaires

• Quality of life for pediatric patients with short bowel syndrome‐associated intestinal failure treated with teduglutide
  par: Danielle Wendel, et autres
  Publié: (2026)
• Teduglutide in adults with short bowel syndrome and intestinal failure: A descriptive cohort study
  par: Elizabeth S. L. Low, et autres
  Publié: (2025)
• Biomarkers for intestinal failure in short bowel syndrome: A new era in GI rehabilitation?
  par: Manuel Enrique Cadena
  Publié: (2019)
• Overview of short bowel syndrome and intestinal transplantation
  par: Debora Duro
  Publié: (2007)
• Teduglutide improves liver chemistries in short bowel syndrome–associated intestinal failure: Post hoc analysis
  par: Dejan Micic, et autres
  Publié: (2024)